Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
Open Access
- 15 September 2020
- journal article
- review article
- Published by Springer Nature in Cell & Bioscience
- Vol. 10 (1) , 1-9
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disease that leads to progressive loss of memory and dementia. The pathological hallmarks of AD include extracellular accumulation of amyloid-β peptides forming senile plaques and intracellular accumulation of Tau oligomers and filamentous species. Tau is a microtubule-binding protein that stabilizes tubulin to form microtubules under physiological condition. In AD/ pathological condition, Tau detaches from microtubules and aggregates to form oligomers of different sizes and filamentous species such as paired helical filaments. Microglia are the resident brain macrophages that are involved in the phagocytosis of microbes, cellular debris, misfolded and aggregated proteins. Chemokine receptor, CX3CR1 is mostly expressed on microglia and is involved in maintaining the microglia in a quiescent state by binding to its ligand, fractalkine (CX3CL1), which is expressed in neurons as both soluble or membrane-bound state. Hence, under physiological conditions, the CX3CR1/CX3CL1 axis plays a significant role in maintaining the central nervous system (CNS) homeostasis. Further, CX3CR1/CX3CL1 signalling is involved in the synthesis of anti-inflammatory cytokines and also has a significant role in cytoskeletal rearrangement, migration, apoptosis and proliferation. In AD brain, the expression level of fractalkine is reduced, and hence Tau competes to interact with its receptor, CX3CR1. In microglia, phagocytosis and internalization of extracellular Tau species occurs in the presence of a chemokine receptor, CX3CR1 which binds directly to Tau and promotes its internalization. In this review, the pathophysiological roles of CX3CR1/fractalkine signalling in microglia and neurons at different stages of Alzheimer’s disease and the possible role of CX3CR1/Tau signalling has been widely discussed.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (CSIR NCL MLP029526)
This publication has 100 references indexed in Scilit:
- Factors regulating microglia activationFrontiers in Cellular Neuroscience, 2013
- Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged ratsNeurobiology of Aging, 2011
- CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer DiseaseJournal of Biological Chemistry, 2011
- Regulation of Tau Pathology by the Microglial Fractalkine ReceptorNeuron, 2010
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and NeurobiologyImmunity, 2009
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathiesNature Reviews Drug Discovery, 2009
- Microtubule assembly, organization and dynamics in axons and dendritesNature Reviews Neuroscience, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- G protein coupled receptor structure and activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007